MNCs Discuss China’s Pharmaceutical Market Outlook
This article was originally published in PharmAsia News
Executive Summary
The recent 2008 new pharmaceutical business development forum in Qingdao, China, organized by Pfizer Investment, aimed to provide a platform for exchanging knowledge and analyses for the drug community. Pharmaceutical giants such as Xian-Janssen, Johnson & Johnson, Bayer and Novartis shared their business development strategies and market outlook for China, with participation from McKinsey and PricewaterhouseCoopers. Besides continuing to speed up new drug development, launch and patent application, MNCs are shifting from the previous tradition of setting up plants for production, to pursuing mergers and acquisitions to build a firm foothold in the local market. All seek new collaborative approaches to tap the vast potential of the country, according to forum participants. (Click here for more - Chinese Language)